Totally Laparoscopic Distal Gastrectomy for Gastric Cancer
TLDG
Randomized Controlled Trial Comparing the Outcomes of Totally Laparoscopic Distal Gastrectomy and Laparoscopy-assisted Gastrectomy for Gastric Cancer
1 other identifier
interventional
120
1 country
1
Brief Summary
This study was designed as a randomized clinical trial comparing the totally laparoscopic distal gastrectomy with laparoscopy-assisted distal gastroectomy for patients with gastric cancer, in terms of short-term and long-term outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 18, 2022
CompletedFirst Posted
Study publicly available on registry
September 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedSeptember 25, 2024
October 1, 2022
2.3 years
September 18, 2022
September 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative stay
the time from the finish of surgery to discharge
about one week to one month from the finish of surgery
Secondary Outcomes (1)
Survival
3 year
Study Arms (2)
totally laparoscopic distal gastrectomy
EXPERIMENTALpatients in this arm will receive totally laparoscopic distal gastrectomy
laparoscopy-assisted distal gastrectomy
NO INTERVENTIONpatients in this group will receive laparoscopy-assisted distal gastrectomy
Interventions
all the surgical procedure would be finished under laparoscopy
Eligibility Criteria
You may qualify if:
- aged 18-80 years old, no gender limitation;
- primary gastric cancer and planed for distal gastrectomy;
You may not qualify if:
- patients with total or proximal gastrectomy;
- patients with distant metastasis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liu Liulead
Study Sites (1)
Xubing Zhang
Hefei, Other (Non U.s.), 230001, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- the Outcomes Assessor would not know which approach the patient received.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical professor
Study Record Dates
First Submitted
September 18, 2022
First Posted
September 27, 2022
Study Start
September 1, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
September 25, 2024
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share
there is a plan to make individual participant data (IPD) available to other researchers.